Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021)

Koen de Nijs*, Harry J. de Koning, Carlijn van der Aalst, Kevin ten Haaf*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

32 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021)'. Together they form a unique fingerprint.

Medicine and Dentistry